Travelzoo Stock Price, News & Analysis (NASDAQ:TZOO)

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Travelzoo in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TZOO shares.
View TZOO analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 12-month price objectives for Travelzoo's stock. Their TZOO share price targets range from $10.00 to $10.00. On average, they predict the company's share price to reach $10.00 in the next year. This suggests a possible upside of 7.0% from the stock's current price.
View analysts price targets for TZOO or view top-rated stocks among Wall Street analysts.

Travelzoo's stock was trading at $4.45 at the start of the year. Since then, TZOO shares have increased by 110.1% and is now trading at $9.35.
View the best growth stocks for 2023 here.

Travelzoo saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 65,700 shares, a drop of 19.2% from the October 31st total of 81,300 shares. Based on an average daily volume of 132,300 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.8% of the shares of the company are sold short.
View Travelzoo's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our TZOO earnings forecast.

Travelzoo (NASDAQ:TZOO) released its quarterly earnings data on Tuesday, October, 24th. The information services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.07. The information services provider earned $20.60 million during the quarter, compared to the consensus estimate of $18.58 million. Travelzoo had a trailing twelve-month return on equity of 147.61% and a net margin of 13.55%.

59 employees have rated Travelzoo Chief Executive Officer Holger Bartel on Glassdoor.com. Holger Bartel has an approval rating of 44% among the company's employees. This puts Holger Bartel in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Travelzoo investors own include Onconova Therapeutics (ONTX), Allena Pharmaceuticals (ALNA), T2 Biosystems (TTOO), Arbutus Biopharma (ABUS), Amarin (AMRN), Ford Motor (F), Las Vegas Sands (LVS), OPKO Health (OPK), Sorrento Therapeutics (SRNE) and AbbVie (ABBV).

Travelzoo's stock is owned by a variety of retail and institutional investors. Top institutional investors include Acadian Asset Management LLC (2.95%), Trexquant Investment LP (0.44%), Denali Advisors LLC (0.25%), GSA Capital Partners LLP (0.25%), Jump Financial LLC (0.14%) and Walleye Capital LLC (0.12%). Insiders that own company stock include Azzurro Capital Inc, Holger Bartel, Lisa Su and Ralph Bartel.
View institutional ownership trends.

Shares of TZOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.